Walk Through Survey Report at Merck, Sharp and Dohme, West Point, Pennsylvania.
NIOSH 1980 Mar:3 pages
Worker exposures to dexamethasone (50022) were studied at Merck, Sharp and Dohme in West Point, Pennsylvania, on March 21, 1979. The company was under consideration for inclusion in a NIOSH study of the health effects of occupational exposure to adrenocortical steroids. Approximately 161 of the employees at the facility were exposed to dexamethasone during receiving, granulation, compressing, fluid manufacture, and packaging operations. The company had a formal safety and industrial hygiene program. Medical services were furnished by two full time and one part time physician, as well as eight full time nurses. The author concludes that of the operations surveyed, the granulation process entails the greatest potential for exposure to dexamethasone, although the infrequency of the dexamethasone granulation process and the short exposure period would make any quantitative assessment of exposure difficult. Detection of biological effects would also be doubtful for similar reason. He recommends that this work force should be included in the dexamethasone hazard study.
NIOSH-Author; NIOSH-Survey; Field-Study; Region-3; Adrenocortical-hormones; Industrial-hygiene; IWS-105-10;
NTIS Accession No.
NIOSH, Industrial Hygiene Section, Industry-wide Studies Branch, Division of Surveillance, Hazard Evaluations and Field Studies, Cincinnati, Ohio, 3 pages